04:41 PM EST, 11/27/2024 (MT Newswires) -- TC BioPharm ( TCBP ) filed a registration statement with the US Securities and Exchange Commission Wednesday for the potential sale of up to $100 million of securities from time to time in one or more offerings.

The filing covers the sale of the company's American depositary shares representing ordinary shares, debt securities, warrants, rights, and units.

Proceeds from the offering will be used for drug discovery and development programs and general corporate purposes, including working capital, market awareness, capital expenditures, investments, acquisitions, and collaborations, according to the company.